Closing Bell: Nervgen Pharma Corp up on Monday (NGEN)

Nervgen Pharma Corp opened trading today at $2.30 and closed at $2.42. prices ranged from a low of $2.26 to a high of $2.48.

The price advanced 5.22 percent from the previous day's close of $2.30.

During the day across North America, the TSX Composite closed 1.36% at 21848.59, the S&P 500 closed -0.16% at 5464.62, the Dow Jones Industrial Average closed 0.04% at 39150.33 and the Nasdaq Composite closed -0.18% at 17689.36.

Nervgen Pharma Corp traded under NGEN on the Toronto Venture Exchange (TSX-V).

A total of 98,107 shares was traded during the session, with total trades of 158. On average, Nervgen Pharma Corp has traded 48,225 shares in the last five days and 89,277 year-to-date.

The TSX-V market on the whole today saw 3,255 price advancers against 1,987 declines and 89 unchanged.

During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.58 (December 14,2023). Moreover, the shares have advanced 49.38 percent in 52 weeks, while this year, they have eased -10.37%.

Following today's trading, Nervgen Pharma Corp has a market capitalization of $160.83 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.34.

Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Currently, Nervgen Pharma Corp's consensus rating is "Strong Sell" based on 0 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..